BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2017
View Archived Issues
Novel mutation in IDS gene unveiled for Hunter syndrome
Read More
Chugai's RG-6107 named orphan drug in the U.S.
Read More
Autolus completes first dose cohort in APRIL study of AUTO2
Read More
Ultragenyx proposes to acquire Dimension Therapeutics
Read More
Emergent Biosolutions awarded funding to develop antidote spray for cyanide poisoning
Read More
Aeolus Pharmaceuticals' AEOL-10150 safe and well-tolerated in phase I study
Read More
TGFbeta-primed MDSCs as a novel adoptive cellular therapy to treat tumors
Read More
Phase II study of PBI-4050 in Alstrom syndrome shows beneficial clinical effects
Read More
NIH grant to support development of Cel-Sci's rheumatoid arthritis vaccine
Read More
Acceleron Pharma, Celgene amend sotatercept agreement
Read More
First-in-human phase I/II Lipo-MERIT trial of RNA cancer vaccine in malignant melanoma patients
Read More
Board recommends continuation of MGL-3196 studies
Read More
UCB discloses new plasmepsin V inhibitors for malaria treatment
Read More
Teva enters partnership with Nuvelution Pharma to develop Austedo for Tourette syndrome
Read More
Roche divulges BACE1 inhibitors
Read More
WDR5/KMT2A interaction inhibitors presented by OICR
Read More
Boehringer Ingelheim discovers SSAO inhibitors
Read More
Viera Bioscience presents Act Tregs for cardiovascular disorders
Read More
Topline data from phase III LEAP 1 study of lefamulin in community-acquired bacterial pneumonia
Read More
Q BioMed and Sphaera Pharma partner to develop QBM-001 analogue
Read More
Xermelo approved in Europe for carcinoid syndrome diarrhea
Read More
Incysus submits IND to FDA for allogeneic gamma-delta T-cell immunotherapy
Read More
Migalastat awarded FDA fast track designation for Fabry disease
Read More
Topline data reported from phase III IMPACT study of newly approved Trelegy Ellipta
Read More
Safety, efficacy and PK data presented for the novel inhaled bronchodilator AZD-8871
Read More
Arcus enters option and license agreement with Taiho in Japan and select Asian territories
Read More
Ophthotech gives update on Zimura clinical trials
Read More
Acer Therapeutics completes merger with Opexa Therapeutics
Read More
4D Molecular Therapeutics receives additional funding from Cystic Fibrosis Foundation Therapeutics
Read More
Synergy of ISA-101 vaccine and chemotherapy for the treatment of HPV-related diseases
Read More
European approval for Rydapt for two indications in rare, hard-to-treat cancers
Read More